Evidence map›Paper›PMID 33704715›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Enrichment of Melanoma Stem-Like Cells via Sphere Assays.

Nabanita Mukherjee, Karoline A Lambert, David A Norris, Yiqun G Shellman

Open access · hybridAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
12.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. A CD24BMC biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nabanita Mukherjee *Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Karoline A Lambert *Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
David A NorrisDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Yiqun G ShellmanDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. yiqun.shellman@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Study of melanocyte lineage through SASH1 and associated proteinsR01AR074420 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SHELLMAN, YIQUN G · 2020 to 2024
$2.2M
Melanoma Resistance to Apoptosis: Mechanisms and Therapeutic PotentialI01BX000141 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI DAVID A. NORRIS, Yiqun G Shellman · 2009 to 2026
–
BLRD VA I01 BX000141NIAMS NIH HHS R01 AR074420
6 · The paper itself

Abstract

Sphere assays are widely used in vitro techniques to enrich and evaluate the stem-like cell behavior of both normal and cancer cells. Utilizing three-dimensional in vitro sphere culture conditions provide a better representation of tumor growth in vivo than the more common monolayer cultures. We describe how to perform primary and secondary sphere assays, used for the enrichment and self-renewability studies of melanoma/melanocyte stem-like cells. Spheres are generated by growing melanoma cells at low density in nonadherent conditions with stem cell media. We provide protocols for preparing inexpensive and versatile polyHEMA-coated plates, setting up primary and secondary sphere assays in almost any tissue culture format and quantification methods using standard inverted microscopy. Our protocol is easily adaptable to laboratories with basic cell culture capabilities, without the need for expensive fluidic instruments.

Indexed as

AnimalsCell Culture TechniquesCell Line, TumorCell SurvivalHumansMelanomaMiceNeoplastic Stem CellsSpheroids, CellularXenograft Model Antitumor AssaysCancer-initiating cellsCancer stem cellCancer stemnessMelanoma-initiating cellsMelanoma stem cellsSphere assayTumor spheres

Identifiers

PMID33704715
PMCPMC8852693
OpenAlexW3134675889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.